Author(s): Gotthardt M, Eizirik DL, Cnop M, Brom M
Abstract Share this page
Abstract The prevalence of diabetes is 382 million worldwide, and is expected to rise to 592 million in 2035 (http://www.idf.org/diabetesatlas); 2.5-15\% of national annual healthcare budgets are related to diabetes care, potentially increasing to 40\% in high-prevalence countries. Beta cell dysfunction and death are central events in diabetes pathogenesis, but the natural history of beta cell loss remains unknown. Clinical imaging of beta cells will play a pivotal role in developing strategies for optimized diabetes prevention and treatment. Copyright © 2014 Elsevier Ltd. All rights reserved.
This article was published in Trends Endocrinol Metab
and referenced in Journal of Clinical & Medical Genomics